Remedial has failed to save the coronary heart disease!

 Remedial has failed to save the coronary heart disease!

The American company Gilead's remedial drug, Corona, has failed to save the lives of the infected.  According to a recent clinical trial by the World Health Organization (WHO), remedies have been shown to be ineffective in treating or saving lives.  This anti-viral medicine was first used at the beginning of the coronavirus infection.  It was also used in the treatment of a recently infected U.S. president in Corona.  The World Health Organization (WHO) recently tested four possible drugs.  These included Remdicivir, Hydrochlorocaine, Anti-HIV Drug Combination Lopinavir-Retonavir, and Interforan.  The study included patients from 11 countries and 30 countries.  It turned out that the drug did not work for those who had been suffering from coronary heart disease and had been hospitalized for a long time.  Notably, on May 1, the U.S. Food and Drug Administration approved Remedial to be used by the U.S. in an emergency.  Then some countries used it.